Andrographolide Suppresses IL-6/Stat3 Signaling in Peripheral Blood Mononuclear Cells from Patients with Chronic Rhinosinusitis with Nasal Polyps
Authors:
- 7 May 2014
- journal article
- Published by Springer Nature in Inflammation
- Vol. 37 (5) , 1738-1743
Abstract
The mechanisms underlying the pathogenesis of chronic rhinosinusitis with nasal polyps (CRSwNP) remain largely unknown. CRSwNP has garnered considerable public health concern owing to its high incidence and unsatisfactory treatment outcomes. Herbal remedies are promising candidates for the treatment of CRSwNP. We examined the utility of andrographolide, a diterpenoid lactone extracted from the Chinese herb Andrographis paniculata, an anti-inflammatory agent for CRSwNP treatment by evaluating interleukin (IL)-6 and IL-17 production and monitoring T helper 17 (Th17) differentiation of peripheral blood mononuclear cells (PBMCs) isolated from 20 Chinese CRSwNP patients and 11 control subjects. All CRSwNP patients exhibited clinical features of CRSwNP. Andrographolide significantly inhibited IL-6 and IL-17 production, suppressed p-Stat3 expression, and inhibited Th17 differentiation of PBMCs in vitro. These findings suggested that andrographolide has useful anti-inflammatory properties and could be used for the treatment of CRSwNP.Keywords
This publication has 20 references indexed in Scilit:
- Master regulator of intestinal disease: IL-6 in chronic inflammation and cancer developmentSeminars in Immunology, 2014
- Interleukin 6 and Rheumatoid ArthritisBioMed Research International, 2014
- A Multiscale Model of Interleukin‐6–Mediated Immune Regulation in Crohn's Disease and Its Application in Drug Discovery and DevelopmentCPT: Pharmacometrics & Systems Pharmacology, 2014
- Th17 Cells in Immunity and AutoimmunityJournal of Immunology Research, 2013
- Systemic Monocyte‐Derived Dendritic Cells and Associated Th2 Skewing in Chronic RhinosinusitisOtolaryngology–Head and Neck Surgery, 2013
- IL-17A as a regulator of neutrophil survival in nasal polyp disease of patients with and without cystic fibrosisJournal of Cystic Fibrosis, 2012
- EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologistsRhinology journal, 2012
- Modifications of andrographolide to increase some biological activities: a patent review (2006 – 2011)Expert Opinion on Therapeutic Patents, 2012
- Inhibition of NF-κB Expression and Allergen-induced Airway Inflammation in a Mouse Allergic Asthma Model by AndrographolideCellular & Molecular Immunology, 2009
- Rhinosinusitis: Developing guidance for clinical trialsJournal of Allergy and Clinical Immunology, 2006